rpt polo188 Options
Summary Multi-injection pharmaceutical products and solutions including insulin has to be formulated to avoid aggregation and microbial contamination. Small-molecule preservatives and nonionic surfactants such as poloxamer 188 (P188) are thus typically used in protein drug formulations. Nevertheless, mixtures of preservatives and surfactants can in